• Exchange: Munich
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Theravance Inc

+ Add to Watchlist

HVE:GR

16.490 EUR 0.210 1.26%

As of 02:16:11 ET on 08/01/2014.

Snapshot for Theravance Inc (HVE)

Open: 15.925 Day's Range: 15.925 - 16.490 Volume: 0
Previous Close: 16.700 52wk Range: 9.000 - 24.992 1-Yr Rtn: -29.39%

Stock Chart for HVE

No chart data available.
  • HVE:GR 16.490
  • 1D
  • 1M
  • 1Y
16.700
Interactive HVE Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for HVE

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) -0.9480
Est. PEG Ratio -
Market Cap (M EUR) 1,857.33
Shares Outstanding (M) 112.63
30 Day Average Volume 123
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield 4.54%
Cash Dividend (USD) 0.2500
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/06/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for HVE

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for HVE

Theravance Inc., is a biopharmaceutical company. The Company develops small molecule medicines for respiratory disease, bacterial infections, and gastrointestinal disorders.

Rick E WinninghamChairman/President/CEOMichael W AguiarSenior VP/CFO
Bradford J ShaferSenior VP/Secy/Gen CounselLeonard M BlumSenior Vice President
More Company Profile & Key Executives for HVE

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil